UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058036
Receipt number R000066336
Scientific Title One-year prospective study on hydrophobic acrylic trifocal intraocular lens with hydroxyethyl methacrylate
Date of disclosure of the study information 2025/06/01
Last modified on 2025/06/01 08:48:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

One-year prospective study on hydrophobic acrylic trifocal intraocular lens with hydroxyethyl methacrylate

Acronym

One-year prospective study on new hydrophobic acrylic trifocal intraocular lens

Scientific Title

One-year prospective study on hydrophobic acrylic trifocal intraocular lens with hydroxyethyl methacrylate

Scientific Title:Acronym

One-year prospective study on new hydrophobic acrylic trifocal intraocular lens

Region

Japan


Condition

Condition

cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To prospectively investigate the one-year postoperative outcomes of a trifocal intraocular lens made from Clareon, a hydrophobic acrylic material with high water content.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

One-year postoperative best-corrected visual acuity in both eyes and lens clarity.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

cataract surgery

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with bilateral cataracts and no other comorbidities.

Key exclusion criteria

Patients with corneal irregular astigmatism

Patients with a history of corneal refractive surgery, intraocular surgery, or corneal surgery

Patients with ocular diseases other than cataract that may affect visual function

Patients deemed unsuitable by the principal or sub-investigator due to systemic or ophthalmic conditions

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tetsuro
Middle name
Last name Oshika

Organization

Universiyt of Tsukuba

Division name

Department of Ophthalmology

Zip code

305-8575

Address

1-1-1 Tennoudai, Tsukuba, Ibaraki

TEL

029-853-3148

Email

oshika@eye.ac


Public contact

Name of contact person

1st name Tetsuro
Middle name
Last name Oshika

Organization

University of Tsukuba

Division name

Department of Ophthalmology

Zip code

305-8575

Address

1-1-1 Tennoudai, Tsukuba, Ibaraki

TEL

0298533148

Homepage URL


Email

oshika@eye.ac


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Alcon Japan

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Tsukuba

Address

1-1-1 Tennoudai, Tsukuba, Ibaraki

Tel

0298533148

Email

oshika@eye.ac


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

Ibaraki


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 11 Month 03 Day

Date of IRB

2022 Year 11 Month 03 Day

Anticipated trial start date

2022 Year 11 Month 03 Day

Last follow-up date

2025 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 01 Day

Last modified on

2025 Year 06 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066336